Skip to main content
Equibles

FMR LLC

Position in RDY — Dr Reddys Laboratories Ltd

CIK 315066 BOSTON, MA
Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,039,380
-$119,629 QoQ
Shares Held
71,731
-14.3% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 238 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

FMR LLC holds $7,214,215,829 across 49 Drug Manufacturers - Specialty & Generic names. RDY ranks #30 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VTRS
Viatris Inc
 96,662,102 $1,534,994,177
2 ELAN
Elanco Animal Health Inc
 56,948,819 $1,401,510,433
3 HLN
Haleon plc
 120,991,250 $1,128,848,360
4 TEVA
Teva Pharmaceutical Industries Ltd
 30,258,016 $1,025,141,579
5 KNSA
Kiniksa Pharmaceuticals International, plc
 6,971,361 $445,818,534
6 LNTH
Lantheus Holdings, Inc.
 3,879,971 $430,443,982
7 AMLX
Amylyx Pharmaceuticals, Inc.
 16,727,909 $300,433,243
8 UTHR
UNITED THERAPEUTICS Corp
 473,409 $256,507,196

All Filings in RDY

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,039,380 71,731
2026-03-31 $1,159,009 83,683
2025-12-31 $1,217,857 86,742
2025-09-30 $1,259,792 90,114
2025-06-30 $1,613,454 107,349
2025-03-31 $1,292,527 97,993
2024-12-31 $1,462,248 92,606
2024-09-30 $1,249,191 15,723
2024-06-30 $1,188,867 15,604
2024-03-31 $1,445,068 19,701
2023-12-31 $1,381,997 19,862
2023-09-30 $903,279 13,508
2023-06-30 $866,562 13,731
2023-03-31 $910,253 15,989
2022-12-31 $584,464 11,294
2022-09-30 $435,729 8,325
2022-06-30 $491,585 8,875
2022-03-31 $352,324 6,322
2021-12-31 $77,706 1,188
2021-09-30 $14,199 218
2021-06-30 $14,039 191
2021-03-31 $11,233 183
2020-12-31 $17,679 248
2020-09-30 $15,371 221
2020-06-30 $5,354 101
2020-03-31 $1,443,490 35,792